Macquarie Group LTD Inovio Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.66 - $2.79 $5,107 - $8,584
-3,077 Reduced 36.76%
5,294 $14,000
Q1 2021

May 14, 2021
BUY
$8.81 - $16.96 $20,254 - $38,991
2,299 Added 37.86%
8,371 $78,000
Q2 2020

Aug 11, 2020
BUY
$7.14 - $31.69 $43,354 - $192,421
6,072 New
6,072 $164,000

Others Institutions Holding INO

# of Institutions
10
Shares Held
281K
Call Options Held
0
Put Options Held
0
View Full List

About INOVIO PHARMACEUTICALS, INC.

INO Quotes by TradingView
  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $496M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email